Arcudi Iii Louis J Insider Trades

Insider Trading History

Track insider trading activity for Arcudi Iii Louis J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Financial Officer
Holding Value $424k 400,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$824k 400,000 shares
$2.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
President And CEO
Holding Value $520k 400,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.4M 400,000 shares
$30.90
$1.30
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Financial Officer
Holding Value $104k 80,000 shares
Last Trade
May 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.4M 80,000 shares
$30.00
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Financial Officer
Holding Value $84.8k 80,000 shares
Last Trade
May 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 80,000 shares
$2.00
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Financial Officer
Holding Value $92.6k 71,250 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.49M 71,250 shares
$119.10
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Financial Officer
Holding Value $75.5k 71,250 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 71,250 shares
$7.94
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Financial Officer
Holding Value $32.5k 25,000 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.35M 25,000 shares
$173.85
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Financial Officer
Holding Value $26.5k 25,000 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 25,000 shares
$11.59
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Chief Financial Officer
Holding Value $65k 50,000 shares
Last Trade
Jan 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.6M 50,000 shares
$132.00
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Financial Officer
Holding Value $53k 50,000 shares
Last Trade
Jan 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 50,000 shares
$8.80
$1.06
Millendo Therapeutics
Millendo Therapeutics MLND
Chief Financial Officer
Holding Value $78.9k 74,400 shares
Last Trade
Dec 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.6k 74,400 shares
$0.69
$1.06
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $13.8k 32,500 shares
Last Trade
Aug 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 32,500 shares
$7.39
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $115k 270,000 shares
Last Trade
Jan 03, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.84M 270,000 shares
$17.92
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $78.6k 185,000 shares
Last Trade
Jan 03, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 185,000 shares
$12.00
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $78.6k 185,000 shares
Last Trade
Jan 06, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.26M 185,000 shares
$23.04
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $85k 200,000 shares
Last Trade
Dec 10, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.35M 200,000 shares
$31.76
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $128k 300,000 shares
Last Trade
Dec 10, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.14M 300,000 shares
$20.48
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $148k 348,333 shares
Last Trade
May 22, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 348,333 shares
$5.52
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $62.1k 146,000 shares
Last Trade
Nov 13, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$214k 33,500 shares
$6.40
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Chief Financial Officer
Holding Value $47.8k 112,500 shares
Last Trade
Mar 13, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$127k 12,500 shares
$10.16
$0.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up